We are live on ! Find out more
VRM

Vectors Research Management Portfolio holdings

AUM $383M
1-Year Est. Return 30.23%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+30.23%
3 Year Est. Return
+67.25%
5 Year Est. Return
+74.92%
10 Year Est. Return
AUM
$392M
AUM Growth
+$29.2M
Cap. Flow
+$9.67M
Cap. Flow %
2.46%
Top 10 Hldgs %
35.7%
Holding
523
New
76
Increased
111
Reduced
63
Closed
20
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNY icon
401
Sanofi
SNY
$103B
$9K ﹤0.01%
167
WEC icon
402
WEC Energy
WEC
$35.7B
$9K ﹤0.01%
100
WLKP icon
403
Westlake Chemical Partners
WLKP
$763M
$9K ﹤0.01%
+350
New +$9.3K
AXS icon
404
AXIS Capital
AXS
$7.68B
$8K ﹤0.01%
170
DKS icon
405
Dick's Sporting Goods
DKS
$17.5B
$8K ﹤0.01%
80
MFC icon
406
Manulife Financial
MFC
$73.9B
$8K ﹤0.01%
392
OLN icon
407
Olin
OLN
$2.11B
$8K ﹤0.01%
177
PODD icon
408
Insulet
PODD
$11.5B
$8K ﹤0.01%
+30
New +$8.15K
SPYD icon
409
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.62B
$8K ﹤0.01%
207
URI icon
410
United Rentals
URI
$67.2B
$8K ﹤0.01%
24
WAB icon
411
Wabtec
WAB
$49.1B
$8K ﹤0.01%
103
+2
+2% +$162
PVLA
412
Palvella Therapeutics
PVLA
$1.99B
$8K ﹤0.01%
+25
New +$5.48K
SGEN
413
DELISTED
Seagen Inc. Common Stock
SGEN
$8K ﹤0.01%
50
ADNT icon
414
Adient
ADNT
$1.65B
$7K ﹤0.01%
146
BYND icon
415
Beyond Meat
BYND
$292M
$7K ﹤0.01%
+42
New +$5.58K
CPAC
416
Cementos Pacasmayo
CPAC
$1.01B
$7K ﹤0.01%
+1,000
New +$7.37K
EVG
417
Eaton Vance Short Duration Diversified Income Fund
EVG
$141M
$7K ﹤0.01%
+500
New +$6.63K
EVH icon
418
Evolent Health
EVH
$348M
$7K ﹤0.01%
350
FXI icon
419
iShares China Large-Cap ETF
FXI
$4.37B
$7K ﹤0.01%
156
OBDC icon
420
Blue Owl Capital
OBDC
$5.34B
$7K ﹤0.01%
+500
New +$7.18K
PDI icon
421
PIMCO Dynamic Income Fund
PDI
$7.39B
$7K ﹤0.01%
+250
New +$7.22K
PHM icon
422
Pultegroup
PHM
$24.1B
$7K ﹤0.01%
121
RYN icon
423
Rayonier
RYN
$6.55B
$7K ﹤0.01%
220
SJM icon
424
J.M. Smucker
SJM
$12.7B
$7K ﹤0.01%
55
VLO icon
425
Valero Energy
VLO
$90.1B
$7K ﹤0.01%
91

Similar funds

Vectors Research Management's Q2 2021 Portfolio in Review

As of Q2 2021, Vectors Research Management held 523 positions worth $392M, up 8% from $363M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Vectors Research Management's Q2 2021 filing shows 76 new, 111 increased, 63 reduced and 20 closed positions. Its largest new stake was Textron: 6,192 shares worth $426K. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $3.82M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Vectors Research Management's largest Q2 2021 buy was Textron: 6,192 shares worth $426K.
  • Vectors Research Management added most to Vanguard Short-Term Inflation-Protected Securities Index Fund in Q2 2021, an estimated $4.42M increase.
  • Vectors Research Management's biggest Q2 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $3.82M.
  • Vectors Research Management fully exited Boeing in Q2 2021, selling an estimated $24K.
  • Vectors Research Management's ten largest holdings make up 36% of its $392M portfolio in Q2 2021.
  • Vectors Research Management opened 76 new positions and closed 20 in Q2 2021.
  • Vectors Research Management's portfolio value rose 8% quarter-over-quarter to $392M.

Based on Vectors Research Management's 13F filing for Q2 2021, filed 9 Aug 2021.